Evaluating the use of Uromune® autovaccine in recurrent urinary tract infections: a pilot unicenter retrospective study in Reus, Spain

Authors: Simona Iftimie, Paula Ladero-Palacio, Ana F. López-Azcona, Laia Pujol-Galarza, Antoni Pont-Salvadó, Xavier Gabaldó-Barrios, Jorge Joven, Jordi Camps, Antoni Castro, Mercè Pascual-Queralt

Source: BMC Infectious Diseases, Vol 25, Iss 1, Pp 1-15 (2025)

Subject Terms: Antibiotic resistance, Immunotherapy, Recurrent urinary tract infections, Sublingual bacterial vaccine, Uromune® vaccine, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: https://doaj.org/toc/1471-2334

Access URL: https://doaj.org/article/9e450e4ee3214d4abb0f2edc132c7949

Effect of vaccine diluents on the colonization of Salmonella Typhimurium vaccine in chickens

Authors: Siyuan Jia, Andrea R. McWhorter, Samiullah Khan, Nicky-Lee Willson, Daniel M. Andrews, Gregory J. Underwood, Kapil K. Chousalkar

Source: Veterinary and Animal Science, Vol 26, Iss , Pp 100409- (2024)

Subject Terms: Salmonella vaccination, Live bacterial vaccine, Vaccine diluent, Veterinary medicine, SF600-1100

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2451943X24000760; https://doaj.org/toc/2451-943X

Access URL: https://doaj.org/article/23dae3134eae4a628c1577b2ed64a94c

Queuing analysis for improving performance in bacterial vaccine quality control process

Authors: Sallyta Ayu Martha, Akhmad Yunani, Wega Setiabudi, Budi Harsanto

Source: Vaccine: X, Vol 20, Iss , Pp 100550- (2024)

Subject Terms: Vaccine production, Queue analysis, Bacterial vaccine quality control, Indonesia, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2590136224001232; https://doaj.org/toc/2590-1362

Access URL: https://doaj.org/article/c9b83b20184c44f5824d2bf91cd64fdb

A simple method for enrichment of phase I Coxiella burnetii

Authors: Anderson, Matthew W. ^{1, 1}, Binette, Picabo ^{1, 1}, Richards, Crystal ¹, Beare, Paul A. ¹, Heinzen, Robert A. ¹, Long, Carrie M. ^{⁎, 1}

Source: In Journal of Microbiological Methods August 2023 211

H2O2-Inactivated Salmonella typhimurium RE88 Strain as a New Cancer Vaccine Carrier: Evaluation in a Mouse Model of Cancer

Authors: Fan Y, Bai T, Tian Y, Zhou B, Wang Y, Yang L

Source: Drug Design, Development and Therapy, Vol Volume 15, Pp 209-222 (2021)

Subject Terms: cancer vaccine, h2o2 inactivation, re88-pvlt33-ova, whole-cell bacterial vaccine, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.dovepress.com/h2o2-inactivated-salmonella-typhimurium-re88-strain-as-a-new-cancer-va-peer-reviewed-article-DDDT; https://doaj.org/toc/1177-8881

Access URL: https://doaj.org/article/6fa46fa13d384e74ba638e12113db529

Murine Q Fever Vaccination Model Reveals Sex Dimorphism in Early Phase Delayed-Type Hypersensitivity Responses

Authors: Picabo Binette, Mahelat Tesfamariam, Diane Cockrell, Robert A. Heinzen, Crystal Richards, Carl Shaia, Carrie Mae Long

Source: Frontiers in Immunology, Vol 13 (2022)

Subject Terms: Coxiella burnetii, DTH (delayed type hypersensitivity), vaccine allergy, sex dimorphism, Q fever Vaccine (Q-VAX®), bacterial vaccine, Immunologic diseases. Allergy, RC581-607

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fimmu.2022.894536/full; https://doaj.org/toc/1664-3224

Access URL: https://doaj.org/article/40965b3ad1cd4dc08074e97550903f06

Preclinical Animal Models for Q Fever Vaccine Development

Authors: Mahelat Tesfamariam, Picabo Binette, Carrie Mae Long

Source: Frontiers in Cellular and Infection Microbiology, Vol 12 (2022)

Subject Terms: Coxiella burnetii, Q fever, vaccine, animal modeling, guinea pig, bacterial vaccine, Microbiology, QR1-502

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fcimb.2022.828784/full; https://doaj.org/toc/2235-2988

Access URL: https://doaj.org/article/1152888288cd4d6c9f88eac729b29065

Active immunoprophyilaxis with uromune® decreases the recurrence of urinary tract infections at three and six months after treatment without relevant secondary effects

Authors: Cristóbal Ramírez Sevilla, Esther Gómez Lanza, Juan Llopis Manzanera, Jose Antonio Romero Martín, Miguel Ángel Barranco Sanz

Source: BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)

Subject Terms: Urinary tract infection, Prevention, Bacterial vaccine, Infectious and parasitic diseases, RC109-216

File Description: electronic resource

Relation: http://link.springer.com/article/10.1186/s12879-019-4541-y; https://doaj.org/toc/1471-2334

Access URL: https://doaj.org/article/7d8d78c1e6644cf28850929e3490586b

Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults

Authors: Michael L. Landrum, Tahaniyat Lalani, Minoo Niknian, Jason D. Maguire, Duane R. Hospenthal, Ali Fattom, Kimberly Taylor, Jamie Fraser, Kenneth Wilkins, Michael W. Ellis, Paul D. Kessler, Rafaat E. F. Fahim, David R. Tribble

Source: Human Vaccines & Immunotherapeutics, Vol 13, Iss 4, Pp 791-801 (2017)

Subject Terms: bacterial vaccine, recombinant α-toxoid, recombinant panton-valentine leukocidin, staphylococcus aureus, Immunologic diseases. Allergy, RC581-607, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://doaj.org/toc/2164-5515; https://doaj.org/toc/2164-554X

Access URL: https://doaj.org/article/01597b4a87634f8eb98a080d5a3c34fa

Humoral immune response against proteophosphoglycan surface antigens of Entamoeba histolytica elicited by immunization with synthetic mimotope peptides
New approaches to bacterial vaccine development

Authors: Melzer, H., Baier, K., Felici, F., von Specht, B.-U., Wiedermann, G., Kollaritsch, H., Wiedermann, U., Duchene, M.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):179-184

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749501&indx=1&recIds=ETOCCN048749501

Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens
New approaches to bacterial vaccine development

Authors: Stevenson, A., Roberts, M.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):121-128

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749422&indx=1&recIds=ETOCCN048749422

Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-Oprl vaccine in burn patients
New approaches to bacterial vaccine development

Authors: Mansouri, E., Blome-Eberwein, S., Gabelsberger, J., Germann, G., von Specht, B.-U.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):161-166

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749471&indx=1&recIds=ETOCCN048749471

Construction of recombinant S-layer proteins (rSbsA) and their expression in bacterial ghosts - a delivery system for the nontypeable Haemophilus influenzae antigen Omp26
New approaches to bacterial vaccine development

Authors: Riedmann, E. M., Kyd, J. M., Smith, A. M., Gomez-Gallego, S., Jalava, K., Cripps, A. W., Lubitz, W.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):185-192

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749513&indx=1&recIds=ETOCCN048749513

Lipopeptides: adjuvanticity in conventional and genetic immunization
New approaches to bacterial vaccine development

Authors: Mittenbuhler, K., Esche, U. v. d., Heinevetter, L., Bessler, W. G., Huber, M.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):193-200

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749525&indx=1&recIds=ETOCCN048749525

Progress toward the development of a bacterial vaccine vector that induces high-titer long-lived broadly neutralizing antibodies against HIV-1
New approaches to bacterial vaccine development

Authors: Fouts, T. R., DeVico, A. L., Onyabe, D. Y., Shata, M. T., Bagley, K. C., Lewis, G. K., Hone, D. M.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):129-134

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749434&indx=1&recIds=ETOCCN048749434

Effect of in situ expression of human interleukin-6 on antibody responses against Salmonella typhimurium antigens
New approaches to bacterial vaccine development

Authors: Li, Y., Reichenstein, K., Ullrich, R., Danner, T., von Specht, B.-U., Hahn, H. P.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):135-146

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749446&indx=1&recIds=ETOCCN048749446

Identification of the domains of the fibronectin-binding protein I of Streptococcus pyogenes responsible for adjuvanticity
New approaches to bacterial vaccine development

Authors: Schulze, K., Guzman, C. A.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):173-178

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749495&indx=1&recIds=ETOCCN048749495

Immunisation with non-integral OMPs promotes pulmonary clearance of Pseudomonas aeruginosa
New approaches to bacterial vaccine development

Authors: Thomas, L. D., Kyd, J. M., Bastin, D. A., Dunkley, M. L., Cripps, A. W.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):155-160

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749460&indx=1&recIds=ETOCCN048749460

DNA vaccines against chronic lung infections by Pseudomonas aeruginosa
New approaches to bacterial vaccine development

Authors: Staczek, J., Gilleland, L. B., van der Heyde, H. C., Gilleland, H. E.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):147-154

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749458&indx=1&recIds=ETOCCN048749458

Mucosal vaccination with a recombinant OprF-I vaccine of Pseudomonas aeruginosa in healthy volunteers: comparison of a systemic vs. a mucosal booster schedule
New approaches to bacterial vaccine development

Authors: Gocke, K., Baumann, U., Hagemann, H., Gabelsberger, J., Hahn, H., Freihorst, J., von Specht, B. U.

Source: FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY. 37(NO 2-3):167-172

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCCN048749483&indx=1&recIds=ETOCCN048749483